Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9206243 IL-2 derivative polypeptides

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
November 10, 2011
Date of Patent
December 8, 2015
Patent Application Number
13885021
Patent Citations Received
‌
US Patent 12091440 IL2 and peptide-MHC complex fusion proteins and methods of use thereof
0
‌
US Patent 12006347 Superagonists and antagonists of interleukin-2
0
‌
US Patent 12076371 Activatable cytokine polypeptides and methods of use thereof
0
‌
US Patent 12091441 Partial agonists of interleukin-2
0
‌
US Patent 11779632 IL-2 muteins and uses thereof
‌
US Patent 11866476 Masked IL-2-Fc fusion polypeptides
0
‌
US Patent 11926654 Fusion proteins composed of an interleukin-2 mutein and type I interferon
0
‌
US Patent 11945852 IL-2 muteins and uses thereof
0
‌
US Patent 11965008 IL-2 muteins and uses thereof
0
‌
US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9206243
Patent Primary Examiner
‌
Robert Landsman

Find more entities like US Patent 9206243 IL-2 derivative polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo